ReviewOncoTargets and therapy2023

Minimal Residual Disease Monitoring in Radically Treated Non-Small Cell Lung Cancer: Challenges and Future Directions.

Hazel M O'Sullivan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.